GB2025395B - Therapeutically active substituted dibenzyl ethers - Google Patents

Therapeutically active substituted dibenzyl ethers

Info

Publication number
GB2025395B
GB2025395B GB7916670A GB7916670A GB2025395B GB 2025395 B GB2025395 B GB 2025395B GB 7916670 A GB7916670 A GB 7916670A GB 7916670 A GB7916670 A GB 7916670A GB 2025395 B GB2025395 B GB 2025395B
Authority
GB
United Kingdom
Prior art keywords
therapeutically active
active substituted
dibenzyl ethers
substituted dibenzyl
ethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7916670A
Other languages
English (en)
Other versions
GB2025395A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of GB2025395A publication Critical patent/GB2025395A/en
Application granted granted Critical
Publication of GB2025395B publication Critical patent/GB2025395B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
GB7916670A 1978-05-18 1979-05-14 Therapeutically active substituted dibenzyl ethers Expired GB2025395B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/78A IT1096361B (it) 1978-05-18 1978-05-18 Dibenzileteri sostituiti terapeuticamente attivi

Publications (2)

Publication Number Publication Date
GB2025395A GB2025395A (en) 1980-01-23
GB2025395B true GB2025395B (en) 1982-07-28

Family

ID=11208025

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7916670A Expired GB2025395B (en) 1978-05-18 1979-05-14 Therapeutically active substituted dibenzyl ethers

Country Status (29)

Country Link
JP (1) JPS605592B2 (xx)
AR (1) AR219596A1 (xx)
AT (1) AT372950B (xx)
AU (1) AU523053B2 (xx)
CA (1) CA1115718A (xx)
CH (1) CH639075A5 (xx)
DD (1) DD143608A5 (xx)
DE (1) DE2917244C2 (xx)
DK (1) DK153838C (xx)
EG (1) EG14345A (xx)
ES (1) ES480552A1 (xx)
FI (1) FI71309C (xx)
FR (1) FR2426047A1 (xx)
GB (1) GB2025395B (xx)
GR (1) GR68396B (xx)
HU (1) HU182565B (xx)
IE (1) IE48372B1 (xx)
IL (1) IL57245A (xx)
IT (1) IT1096361B (xx)
MX (1) MX5927E (xx)
NL (2) NL189255C (xx)
NO (1) NO152840C (xx)
NZ (1) NZ190412A (xx)
PH (1) PH14782A (xx)
PT (1) PT69537A (xx)
SE (1) SE444812B (xx)
SU (1) SU816399A3 (xx)
YU (1) YU112279A (xx)
ZA (1) ZA792015B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155853A (en) * 1980-06-06 1983-10-25 Joseph A. Martin Imidazole derivatives and preparation thereof
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
FR2541114B1 (fr) * 1983-02-23 1986-04-11 Sanofi Sa Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
ES2249992B1 (es) 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Also Published As

Publication number Publication date
GB2025395A (en) 1980-01-23
CA1115718A (en) 1982-01-05
JPS605592B2 (ja) 1985-02-12
IT7823546A0 (it) 1978-05-18
FR2426047B1 (xx) 1982-11-05
DE2917244C2 (de) 1985-09-05
SE7904319L (sv) 1979-11-19
NL930014I1 (nl) 1993-05-03
DE2917244A1 (de) 1979-11-22
NL930014I2 (nl) 1993-09-16
IT1096361B (it) 1985-08-26
GR68396B (xx) 1981-12-29
NL189255C (nl) 1993-02-16
IE48372B1 (en) 1984-12-26
IL57245A (en) 1983-02-23
NO791599L (no) 1979-11-20
SU816399A3 (ru) 1981-03-23
FI71309C (fi) 1986-12-19
PH14782A (en) 1981-12-09
DK196579A (da) 1979-11-19
JPS54151974A (en) 1979-11-29
DK153838B (da) 1988-09-12
ZA792015B (en) 1980-04-30
SE444812B (sv) 1986-05-12
DK153838C (da) 1989-01-30
HU182565B (en) 1984-02-28
EG14345A (en) 1983-09-30
YU112279A (en) 1983-01-21
CH639075A5 (fr) 1983-10-31
FR2426047A1 (fr) 1979-12-14
MX5927E (es) 1984-08-29
NO152840C (no) 1985-11-27
NL7903872A (nl) 1979-11-20
IE790958L (en) 1979-11-18
DD143608A5 (de) 1980-09-03
FI791543A (fi) 1979-11-19
ES480552A1 (es) 1980-04-01
IL57245A0 (en) 1979-09-30
AU4714979A (en) 1979-11-22
NZ190412A (en) 1981-03-16
FI71309B (fi) 1986-09-09
AT372950B (de) 1983-11-25
AU523053B2 (en) 1982-07-08
PT69537A (fr) 1979-05-01
NO152840B (no) 1985-08-19
ATA345079A (de) 1983-04-15
AR219596A1 (es) 1980-08-29

Similar Documents

Publication Publication Date Title
ZA797054B (en) Pharmaceutically active compounds
GB2025195B (en) Combined mowerconditioner
GB2025398B (en) Gephalosporin antibiotics
IL57398A0 (en) Cepahlosporin antibiotics
JPS54118666A (en) Pulverizer
GB2041360B (en) Antibiotic
JPS5570354A (en) Pulverizer
GB2032913B (en) Antibiotic sb-72310
GB2025395B (en) Therapeutically active substituted dibenzyl ethers
GB2016448A (en) Therapeutically useful n-phenylaniline derivatives
GB2021582B (en) Antibiotics
JPS55106186A (en) Active doll
GB2015907B (en) Cluster mills
GB2028806B (en) Streptomycin antibiotics
GB2030568B (en) Monophosphates
JPS55106187A (en) Active doll
GB2016012B (en) Pharmaceutically active decahydro-isoquinoline derivatives
PH15350A (en) Anthelmintic
JPS5559850A (en) Pulverizer
GB1483448A (en) Therapeutically active basic ethers
GB2012854B (en) Structures
JPS54129489A (en) Swtich
JPS54148780A (en) Antiitumor active novel 55iminoo44hydroxymethyll 33isooxazolidones
JPS55129247A (en) Novel therapeutically active spirocycloalkylamines
JPS54100320A (en) Therapeutically effective pseudoopeptide

Legal Events

Date Code Title Description
711A Proceeding under section 117(1) patents act 1977
CTFF Supplementary protection certificate filed

Free format text: SPC/GB93/107, 930628

CTFG Supplementary protection certificate granted

Free format text: SPC/GB93/107, 931112, EXPIRES:20001013

PE20 Patent expired after termination of 20 years

Effective date: 19990513

CTFL Supplementary protection certificate lapsed

Free format text: SPC/GB93/107, 19991113